Supplement GMPs
This article was originally published in The Tan Sheet
Executive Summary
Proposed reg could face another long delay as it undergoes reexamination by FDA/HHS under Bush Administration following withdrawal from OMB Feb. 1 (1"The Tan Sheet" Feb. 5, In Brief). Reg may have to wait for new FDA commissioner and likely would be an issue at confirmation hearings, industry sources speculate. Last acting commissioner served approximately 20 months
You may also be interested in...
E'Ola Appealing $13.3 Mil. Ephedrine Supplement Verdict
A $13.3 mil. jury verdict for an Alaska woman who claimed her stroke was caused by ephedrine alkaloid-containing dietary supplements could open the door to new lawsuits against the industry.
Supplement GMPs
FDA's proposed reg "withdrawn by agency" Feb. 1, according to OMB Web site. Long-awaited reg, which was sent to OMB in November, is one of many rulemakings affected by Bush Administration memorandum stating no proposed or final regs at OMB should be sent to Office of Federal Register until "a department or agency head" appointed by President Bush "reviews and approves the regulatory action" (1"The Tan Sheet" Jan. 29, p. 3)
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC